Protara Therapeutics, Inc. (TARA) › Total AssetsProtara Therapeutics, Inc. (TARA) — Total AssetsAnnual figures by period end, from SEC filings.2013-12-31: $5.66M2014-12-31: $84.80M2015-12-31: $67.54M2016-12-31: $43.52M2017-12-31: $43.98M2018-12-31: $23.52M2019-12-31: $1.22M2020-12-31: $203.16M2021-12-31: $172.60M2022-12-31: $113.29M2023-12-31: $78.95M2024-12-31: $181.45M2025-12-31: $209.47M$209.47M2013-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$209.47M+15.4%2026-03-10Balance as of period end2024-12-31$181.45M+129.8%2026-03-10Balance as of period end2023-12-31$78.95M-30.3%2025-03-05Balance as of period end2022-12-31$113.29M-34.4%2024-03-13Balance as of period end2021-12-31$172.60M-15.0%2023-03-08Balance as of period end2020-12-31$203.16M+16511.4%2022-03-09Balance as of period end2019-12-31$1.22M-94.8%2021-03-11Balance as of period end2018-12-31$23.52M-46.5%2020-03-20Balance as of period end2017-12-31$43.98M+1.1%2019-03-13Balance as of period end2016-12-31$43.52M-35.6%2018-03-14Balance as of period end2015-12-31$67.54M-20.4%2017-03-16Balance as of period end2014-12-31$84.80M+1398.5%2016-03-14Balance as of period end2013-12-31$5.66M—2015-03-20Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)